✦ LIBER ✦
OP-09 Pharmacokinetic characteristics of the new treatment combination of sorafenib and resminostat, a novel histone deacetylase (HDAC) inhibitor, in patients with advanced hepatocellular carcinoma (HCC): The SHELTER study
✍ Scribed by Hauns, B.; Mais, A.; Doblhofer, R.; Henning, S.W.; Hentsch, B.; Bitzer, M.
- Book ID
- 122043786
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 58 KB
- Volume
- 45
- Category
- Article
- ISSN
- 1590-8658
No coin nor oath required. For personal study only.